Henry Schein (NASDAQ:HSIC) Shares Gap Up – Here’s Why

Shares of Henry Schein, Inc. (NASDAQ:HSIC) gapped up before the market opened on Tuesday . The stock had previously closed at $77.64, but opened at $80.56. Henry Schein shares last traded at $75.78, with a volume of 1,004,639 shares traded.

Analysts Set New Price Targets

HSIC has been the topic of several recent analyst reports. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Wells Fargo & Company started coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Eight analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Stock Down 2.2 %

The company has a market capitalization of $9.46 billion, a PE ratio of 31.23, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a 50 day simple moving average of $74.19 and a two-hundred day simple moving average of $72.38.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the business earned $0.66 earnings per share. Research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Hedge Funds Weigh In On Henry Schein

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Versant Capital Management Inc boosted its stake in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares in the last quarter. Investment Management Corp VA ADV acquired a new stake in Henry Schein in the fourth quarter valued at $32,000. Venturi Wealth Management LLC boosted its position in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares in the last quarter. Quent Capital LLC grew its stake in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC increased its holdings in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.